Hardback : £90.27
Section I. Overview 1. Basal Ganglia Anatomy, Biochemistry, and Physiology 2. Cerebellar Anatomy, Biochemistry, Physiology, and Plasticity 3. Classification of Movement Disorders 4. Diagnostic Evaluation of Children with Movement Disorders 5. Motor Assessments
Section II. Developmental Movement Disorders 6. Transient and Developmental Movement Disorders
Section III. Paroxysmal Movement Disorders 7. Tics and Tourette Syndrome 8. Motor Stereotypies 9. Paroxysmal Dyskinesias
Section IV. Hyperkinetic and Hypokinetic Movement Disorders 10. Chorea, Athetosis, and Ballism 11. Dystonia 12. Myoclonus 13. Tremor 14. Ataxia 15. Parkinsonism 16. Hereditary Spastic Paraplegia
Section V. Selected Secondary Movement Disorders 17. Metabolic Disorders with Associated Movement Abnormalities 18. Movement Disorders in Autoimmune Diseases 19. Movement Disorders in Sleep 20. Cerebral Palsy 21. Movement Disorders and Neuropsychiatric Conditions 22. Drug-Induced Movement Disorders in Children 23. Functional Movement Disorders
Appendix A: Drug Appendix Appendix B: Search Strategy for Genetic Movement Disorders
Show more
Section I. Overview 1. Basal Ganglia Anatomy, Biochemistry, and Physiology 2. Cerebellar Anatomy, Biochemistry, Physiology, and Plasticity 3. Classification of Movement Disorders 4. Diagnostic Evaluation of Children with Movement Disorders 5. Motor Assessments
Section II. Developmental Movement Disorders 6. Transient and Developmental Movement Disorders
Section III. Paroxysmal Movement Disorders 7. Tics and Tourette Syndrome 8. Motor Stereotypies 9. Paroxysmal Dyskinesias
Section IV. Hyperkinetic and Hypokinetic Movement Disorders 10. Chorea, Athetosis, and Ballism 11. Dystonia 12. Myoclonus 13. Tremor 14. Ataxia 15. Parkinsonism 16. Hereditary Spastic Paraplegia
Section V. Selected Secondary Movement Disorders 17. Metabolic Disorders with Associated Movement Abnormalities 18. Movement Disorders in Autoimmune Diseases 19. Movement Disorders in Sleep 20. Cerebral Palsy 21. Movement Disorders and Neuropsychiatric Conditions 22. Drug-Induced Movement Disorders in Children 23. Functional Movement Disorders
Appendix A: Drug Appendix Appendix B: Search Strategy for Genetic Movement Disorders
Show moreSection I. Overview
1. Basal Ganglia Anatomy, Biochemistry, and Physiology
2. Cerebellar Anatomy, Biochemistry, Physiology, and Plasticity
3. Classification of Movement Disorders
4. Diagnostic Evaluation of Children with Movement Disorders
5. Motor Assessments
Section II. Developmental Movement Disorders
6. Transient and Developmental Movement Disorders
Section III. Paroxysmal Movement Disorders
7. Tics and Tourette Syndrome
8. Motor Stereotypies
9. Paroxysmal Dyskinesias
Section IV. Hyperkinetic and Hypokinetic Movement Disorders
10. Chorea, Athetosis, and Ballism
11. Dystonia
12. Myoclonus
13. Tremor
14. Ataxia
15. Parkinsonism
16. Hereditary Spastic Paraplegia
Section V. Selected Secondary Movement Disorders
17. Metabolic Disorders with Associated Movement Abnormalities
18. Movement Disorders in Autoimmune Diseases
19. Movement Disorders in Sleep
20. Cerebral Palsy
21. Movement Disorders and Neuropsychiatric Conditions
22. Drug-Induced Movement Disorders in Children
23. Functional Movement Disorders
Appendix A: Drug Appendix
Appendix B: Search Strategy for Genetic Movement Disorders
Harvey S. Singer MD is currently Professor Emeritus at the Johns
Hopkins University School of Medicine and active faculty member at
the Kennedy Krieger Institute. He grew up in the Bronx and Long
Island, went to college and medical school in Ohio (Oberlin College
and Western Reserve Univ.), did his pediatric training in Chicago
and Cleveland, and his pediatric neurology residency at the Johns
Hopkins Hospital. After completing his training, Dr Singer remained
on the active faculty at Hopkins for 45 years. He was Director of
Pediatric Neurology from 1991 – 2011. He was the first recipient
(2013) of the Child Neurology Society’s Blue Bird Circle Training
Program Director Award and a Hower Award lecturer (2016). His
clinical research interests include movement disorders, especially
Tourette syndrome, stereotypic movements, and proposed autoimmune
disorders. His translational research-oriented laboratory focuses
on the neurobiology of stereotypic movements and tics. He has been
the recipient of federal and private grants, authored numerous
original articles, chapters, and three books. He enjoys biking,
travel, visiting his five grandchildren, and work. Jonathan W.
Mink, MD PhD is the Frederick A. Horner, MD Distinguished Professor
in Pediatric Neurology at the University of Rochester, where is
also Professor of Neurology, Neuroscience, and Pediatrics. He is
currently Chief of the Child Neurology Division and Vice Chair of
the Department of Neurology at the University of Rochester. He
graduated from the Medical Scientist Training Program at Washington
University and then completed residency training in Child Neurology
at St. Louis Children’s Hospital. He completed a fellowship in
Movement Disorders at Washington University and remained on the
faculty there until moving to his current position at the
University of Rochester in 2001. His research interests include
basal ganglia mechanisms in movement disorders, experimental
therapeutics in pediatric movement disorders, and multiple avenues
of investigation in the neuronal ceroid lipofuscinoses (Batten
diseases). He is a former member of the NINDS Advisory Council and
the FDA Pediatric Advisory Committee. He has served as President of
the Child Neurology Society. He has received numerous award in
recognition of his contributions including the Derek Denny-Brown
Award from the American Neurological Association, the Oliver Sacks
Award from the Tourette Association of America, and the Hower Award
from the Child Neurology Society. Donald L. Gilbert, MD, earned his
Bachelor of Arts at Princeton University, where he majored in
philosophy. He subsequently earned his MD at the University of
Michigan and spent a year at the National Institutes of Health as a
Howard Hughes Medical Institute Research Scholar. Dr. Gilbert
trained in pediatrics and pediatric neurology at Johns Hopkins in
Baltimore and is board certified in neurology with special
competence in child neurology. Dr. Gilbert has an MS in clinical
research design and statistical analysis from the University of
Michigan.At Cincinnati Children's, Dr. Gilbert directs the Movement
Disorders and Tourette Syndrome Clinics, which specializes in
evaluation and pharmacologic treatment of tics, tremor, chorea,
ataxia, dystonia, stereotypies, drug-induced movement disorders,
paroxysmal movement disorders, and functional movement disorders
https://www.cincinnatichildrens.org/service/m/movement. Dr. Gilbert
directs or participates in a number of single and multi-center
studies into causes and treatments of Tourette syndrome and
pediatric movement disorders. Dr. Gilbert also studies
physiological mechanisms of motor control in Tourette Syndrome and
Attention Deficit Hyperactivity Disorder in childhood at the
Transcranial Magnetic Stimulation Laboratory
https://www.cincinnatichildrens.org/research/divisions/n/neurology/labs/gilbert-wu
at Cincinnati Children's. Joseph Jankovic, M.D. is Professor of
Neurology, Distinguished Chair in Movement Disorders, and Founder
and Director of the Parkinson's Disease Center and Movement
Disorders Clinic (PDCMDC), Department of Neurology, Baylor College
of Medicine, Houston, Texas. After completing his Neurology
training at Columbia University, New York City, he joined the
faculty of Baylor College of Medicine in 1977. Since that time he
has led clinical team that focuses on the most compassionate and
expert care and research on etiology, pathophysiology, and
experimental therapeutics of Parkinson’s disease and related
neurodegenerative and movement disorders such as tremors, dystonia,
Tourette syndrome, Huntington disease, restless legs syndrome,
tardive dyskinesia, and paroxysmal dyskinesias. Under the direction
of Dr. Jankovic the PDCMDC has been recognized as "Center of
Excellence" by the Parkinson’s Foundation, the Huntington Disease
Society of America, the Tourette Association of America, and the
Wilson Disease Association.
Past president of the International Parkinson and Movement Disorder
Society and of the International Neurotoxin Association, Dr.
Jankovic is the recipient of many awards including the American
Academy of Neurology (AAN) Movement Disorders Research Award, First
National Parkinson Foundation Distinguished Service Award,
Huntington’s Disease Society of America Guthrie Family Humanitarian
Award, Tourette Syndrome Association Lifetime Achievement Award,
Dystonia Medical Research Foundation Distinguished Service Award,
Benign Essential Blepharospasm Research Foundation Award, and
Lifetime Achievement Award from the International Neurotoxin
Association, Dr. Jankovic has been recognized as an Honorary Member
of the American Neurological Association, Australian Association of
Neurologists, French Neurological Society, and the International
Parkinson’s Disease and Movement Disorders Society. Dr. Jankovic
has published over 1,200 original articles and over 55 books, is
included among “Highly Cited Researchers, and has been ranked #1
expert in the world in movement disorders and in botulinum toxins
(http://expertscape.com/). He has served as the principal
investigator in hundreds of clinical trials and his pioneering
research on drugs for parkinsonian disorders and hyperkinetic
movement disorders has led to their approval by the Food and Drug
Administration. Certified by the American Board of Psychiatry and
Neurology, Dr. Jankovic is a fellow of the AAN and current or past
member of many scientific and medical advisory boards and has
served on the executive scientific advisory boards of the Michael
J. Fox Foundation for Parkinson’s Research and the National
Parkinson Foundation. Dr. Jankovic has mentored numerous fellows
and other trainees many of whom have become leaders in the field of
neurology and movement disorders. For further information visit
www.jankovic.org.
![]() |
Ask a Question About this Product More... |
![]() |